AMGN vs. AZN: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and AZN, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AZN stands out with 432.07 billion USD in market value—about 2.96× AMGN’s market cap of 145.90 billion USD.
AMGN’s beta of 0.50 points to much larger expected swings compared to AZN’s calmer 0.18, suggesting both higher upside and downside potential.
AZN is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike AMGN, which is purely domestic.
| Symbol | AMGN | AZN |
|---|---|---|
| Company Name | Amgen Inc. | AstraZeneca PLC |
| Country | US | GB |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Robert A. Bradway | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. |
| Price | 271.34 USD | 69.68 USD |
| Market Cap | 145.90 billion USD | 432.07 billion USD |
| Beta | 0.50 | 0.18 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | June 17, 1983 | May 12, 1993 |
| ADR | No | Yes |
Performance Comparison
This chart compares the performance of AMGN and AZN over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and AZN, please refer to the table below.
| Symbol | AMGN | AZN |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 27.80 |
| Forward PEG Ratio (TTM) | 7.08 | 2.50 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 3.93 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 5.26 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 22.33 |
| EV-to-EBITDA (TTM) | 15.71 | 13.68 |
| EV-to-Sales (TTM) | 5.70 | 4.41 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 25.07 |
Dividend Comparison
AMGN’s dividend yield of 3.41% is about 146% higher than AZN’s 1.39%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | AMGN | AZN |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 1.39% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and AZN, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AZN’s current ratio of 0.90 indicates its assets may not cover near-term debts, whereas AMGN at 1.17 maintains healthy liquidity.
- AZN posts a quick ratio of 0.70, indicating limited coverage of short-term debts from its most liquid assets—while AMGN at 0.88 enjoys stronger liquidity resilience.
- AMGN is heavily leveraged (debt-to-equity ratio 9.24), which can boost returns but raises risk if borrowing costs climb, while AZN at 0.77 keeps leverage at a more moderate level.
| Symbol | AMGN | AZN |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 0.90 |
| Quick Ratio (TTM) | 0.88 | 0.70 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 0.77 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.30 |
| Interest Coverage Ratio (TTM) | 3.19 | 7.95 |